Evotec SE’s Seattle-based subsidiary, Just – Evotec Biologics Inc., has received a new grant from the Gates Foundation to enable global access to biotherapeutics utilizing Just – Evotec Biologics’ molecular design suite of computational technologies, called “J.MD.” Under the grant terms, Just – Evotec Biologics will leverage its J.MD Molecular Design service—a key component of its J.DESIGN platform, which integrates advanced computational tools and high-throughput methodologies—to streamline ...